Background Belimumab and low dose IL2 (Ld-IL2) has been identified effective in the treatment of systemic lupus erythematosus (SLE). However, the application of combined therapy for SLE has not been ...

Objective To evaluate the clinical utility of the multianalyte assay panel (MAP), commercially known as AVISE Lupus test (Exagen Inc.), in patients suspected of SLE.Methods A systematic review of ...

Background and aims The many manifestations of Lupus can jeopardise aspects of daily living in those with the disease. The aim of this study was to synthesise findings of primary and secondary studies ...